Achilles Therapeutics (ACHL)
(Delayed Data from NSDQ)
$0.82 USD
-0.02 (-2.23%)
Updated Jul 16, 2024 01:45 PM ET
3-Hold of 5 3
F Value B Growth A Momentum C VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 8/2/24 |
---|---|
Current Quarter | -0.41 |
EPS Last Quarter | -0.30 |
Last EPS Surprise | 34.78% |
ABR | 2.67 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -1.26 |
Next Year | -1.32 |
EPS (TTM) | -1.60 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | NA | NA | NA |
# of Estimates | NA | NA | NA | NA |
High Estimate | NA | NA | NA | NA |
Low Estimate | NA | NA | NA | NA |
Year ago Sales | 0.00M | 0.00M | NA | NA |
Year over Year Growth Est. | NA | NA | NA | NA |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.41 | -0.48 | -1.26 | -1.32 |
# of Estimates | 2 | 1 | 3 | 3 |
Most Recent Consensus | NA | NA | -1.82 | -1.74 |
High Estimate | -0.33 | -0.48 | -0.19 | -0.12 |
Low Estimate | -0.49 | -0.48 | -1.82 | -2.09 |
Year ago EPS | -0.42 | -0.42 | -1.74 | -1.26 |
Year over Year Growth Est. | 2.38% | -14.29% | 27.59% | -4.76% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 0 | 0 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.41 | -0.48 | -1.26 | -1.32 |
7 Days Ago | -0.41 | -0.48 | -1.26 | -1.32 |
30 Days Ago | -0.41 | -0.48 | -1.26 | -1.32 |
60 Days Ago | -0.41 | -0.48 | -1.26 | -1.32 |
90 Days Ago | -0.48 | -0.48 | -1.34 | -1.33 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.41 | -0.48 | -1.26 | -1.32 |
Zacks Consensus Estimate | -0.41 | -0.48 | -1.26 | -1.32 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.30 | -0.46 | -0.42 | -0.42 | NA |
Estimate | -0.46 | NA | -0.38 | -0.40 | NA |
Difference | 0.16 | NA | -0.04 | -0.02 | 0.03 |
Surprise | 34.78% | NA | -10.53% | -5.00% | 6.42% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more